Collegium Pharmaceutical Stock Price

0.00 (0.0%)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Collegium Pharmaceutical Inc COLL NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.33 -1.97% 16.40 16.40 17.40 17.01 16.73 17:15:00
Bid Price Ask Price Spread Spread % News
15.51 17.50 1.99 11.37% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,287 286,470 $ 17.02 $ 4,876,875 451,422 10.01 - 25.60
Last Trade Time Type Quantity Stock Price Currency
16:00:18 priorref 3,780 $ 16.40 USD

Collegium Pharmaceutical Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 563.11M 34.34M 29.45M $ 296.70M $ -10.41M -0.67 -54.07
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -37.26k 2.50%

more financials information »

Collegium Pharmaceutical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical COLL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week17.7617.8816.1617.11414,831-1.36-7.66%
1 Month17.1718.8916.1617.37377,816-0.77-4.48%
3 Months19.2724.31916.1619.69440,811-2.87-14.89%
6 Months23.5025.6013.0020.49579,047-7.10-30.21%
1 Year11.4025.6010.0118.57466,1495.0043.86%
3 Years12.2729.909.0117.89490,3694.1333.66%
5 Years17.97430.587.3717.17394,041-1.57-8.76%

Collegium Pharmaceutical Description

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing and dissolving. Its product Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone.

Your Recent History
Collegium ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.